GEORGE F. GAO
Instituição: DPhil (Oxon)
Titulo da palestra:
Member (academician) of Chinese Academy of Sciences, a foreign associate of National Academy of Sciences (NAS, elected in 2019) and so on. Director-General of Chinese Center for Disease Control and Prevention, and Director and Professor of CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences.
Professor Gao obtained his PhD (DPhil) degree from Oxford University, UK and did his postdoc work in both Oxford University and Harvard University (with a brief stay in Calgary University). His research interests include enveloped viruses and molecular immunology. His group research is mainly focusing on the enveloped virus entry and release, esp. influenza virus interspecies transmission (host jump), structure-based drug-design and structural immunology. He is also interested in virus ecology, esp. the relationship between influenza virus and migratory birds or live poultry markets and the bat-derived virus ecology and molecular biology. He has published lots of refereed papers (Including papers in Cell, Nature, Science, The Lancet, New England Journal of Medicine, Proceedings of the National Academy of Sciences USA etc.). His research has recently expanded on public health policy and global health strategy. Gao is a recipient of several international and national awards, including TWAS Medical Prize (2012), Nikkei Asian Prize (Japan 2014), Shulan Medical Sciences Award (2016), the Gamaleya Medal (Russia 2018), HKU Centennial Distinguished Chinese Scholar (2019) and the Qiu Shi Outstanding Scientist and Outstanding Scientific Research Team Awards (2019).
RAFAEL ELIAS MARQUES PEREIRA SILVA
Instituição: Centro Nacional de Pesquisa em Energia e Materiais
Titulo da palestra: The structure of Mayaro virus
Biólogo, concluiu o mestrado e o doutorado pelo departamento de Bioquímica e Imunologia da UFMG, sob a orientação do Prof. Mauro Martins Teixeira. Durante sua formação, estudou mecanismos inflamatórios envolvidos e potenciais tratamentos contra arboviroses. Desenvolveu parte do doutorado sob a supervisão do Prof. Johan Neyts, na Bélgica, trabalhando em uma nova plataforma de vacinação contra flavivirus e screening de compostos antivirais. Atualmente é pesquisador no Centro Nacional de Pesquisa em Energia e Materiais - CNPEM, onde lidera um grupo de pesquisa voltado ao estudo de arbovirus negligenciados com foco em: modelos experimentais de infecção in vitro e in vivo, descoberta de fármacos e biologia estrutural.
ALICE FREITAS VERSIANI
Instituição: Faculdade de Medicina de São José do Rio Preto (FAMERP)
Titulo da palestra: Virus nanotechnology: new frontiers for diagnostic and vaccine tools
Possui graduação em Medicina Veterinária pela Universidade Federal de Viçosa (UFV). Mestre e Doutora em Microbiologia pelo Programa de Pós-Graduação em Microbiologia da Universidade Federal de Minas Gerais (UFMG). Realizou seu Doutorado Sanduíche no Institute for Medical Engineering and Science (IMES) do Massachusetts Institute of Technology (MIT). Atualmente é Docente no programa de Pós-graduação em Ciências da Saúde na FAMERP e realiza Pós-doutorado no Laboratório de Pesquisa em Virologia na Faculdade de Medicina de São José do Rio Preto (FAMERP). Consultora ad hoc da Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). Tem experiência na área de Microbiologia, com ênfase em Virologia, atuando principalmente com Biologia Molecular, Expressão de Proteínas, Imunodiagnóstico e produção de Vacinas de Subunidades. Sua principal linha de pesquisa é voltada à Nanobiomedicina, sendo co-fundadora e membro do Nanobiomedical Research Group (nanobiomrg.com), sediado na UFMG e com colaborações nacionais e internacionais na área. Realiza pesquisas com nanomateriais de ouro e carbono para o desenvolvimento de plataformas diagnósticas alternativas e carreadores vacinais para doenças infecciosas e crônicas.
WILLIAM MARCIEL DE SOUZA
Instituição: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
Titulo da palestra: Epidemiology, genomics, and pathogenesis of arboviruses and SARS-CoV-2
Biomédico pela Universidade do Oeste de Santa Catarina (2010). Mestrado (2013) e Doutorado (2017) em Ciências pelo Programa de Pós-Graduação de Imunologia Básica e Aplicada da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo. Realizou estágio doutoral no Centre for Virus Research - University of Glasgow, Escócia (2015-2016). Membro do International Committee of Taxonomy of Viruses (ICTV) - Peribunyaviridae Study Group e Hepeviridae Study Group. Tem experiência em microbiologia, com ênfase em virologia, atuando em estudos prospectivos, genômicos e evolutivos de vírus zoonóticos, emergentes e re-emergentes.
Instituição: The Ohio State University
Titulo da palestra: Contemplating Phage Therapy as a Phage Ecologist
Steve Abedon received his Ph.D. in Microbiology with a minor in Ecology and Evolutionary Biology in 1990 from the University of Arizona. He has been a Professor of Microbiology since 1995 at the Ohio State University. His main research interests focus on the ecology, evolutionary ecology, pharmacology, biofilm interactions, and history of bacteriophages. He has well over 100 publications, plus has edited or co-edited a half a dozen volumes on phage biology and single-authored one monograph. According to Google Scholar, his h-index is over 45 and his i10 index is over 90.
MICHEL C. NUSSENZWEIG
Instituição: The Rockefeller University
Titulo da palestra: Human immune responses to SARS-Cov-2 infection and vaccination
Michel Nussenzweig was born in Sao Paulo Brazil on February 10th 1955. He received a B.S. summa cum laude from New York University in 1976, a Ph.D. degree from the Rockefeller University in 1981 and an M.D. degree from New York University Medical School in 1982. During his PhD with Ralph Steinman he discovered that dendritic cells are antigen presenting cells. After completing a medical internship, and residency, and infectious fellowship at the Massachusetts General Hospital he joined Dr. Philip Leder in the department of genetics at Harvard Medical School for postdoctoral training. He returned to Rockefeller University in 1990 as an assistant professor and Howard Hughes Investigator to head an independent laboratory. He was promoted to professor in 1996 and holds the Zanvil A. Cohn and Ralph M. Steinman Chair of Immunology. He is a member of the American Academy of Arts and Sciences, the US National Academy of Medicine and the US National Academy of Sciences.
Instituição: Icahn School of Medicine at Mount Sinai
Titulo da palestra: COVID-19 vaccine based on a Newcastle disease virus (NDV) vector
Peter Palese is a Professor of Microbiology and the Chair of the Department of Microbiology at the Icahn School of Medicine at Mount Sinai. His research is in the area of RNA-containing viruses with a special emphasis on influenza viruses. Specifically, he established the first genetic maps for influenza A, B, and C viruses, identified the function of several viral genes, and defined the mechanism of neuraminidase inhibitors (which are now FDA-approved antivirals). He was also a pioneer in the field of reverse genetics for negative strand RNA viruses, which allows the introduction of site-specific mutations into the genomes of these viruses. This technique is crucial for the study of the structure/function relationships of viral genes, for investigation of viral pathogenicity and for development and manufacture of novel vaccines. An improvement of this technique has been effectively used by him and his colleagues to reconstruct and study the pathogenicity of the highly virulent, but extinct, 1918 pandemic influenza virus. Work in collaboration with Adolfo Garcia-Sastre has revealed that most negative strand RNA viruses possess proteins with interferon antagonist activity, enabling them to counteract the antiviral response of the infected host. In recent years most of the efforts by Palese and by his collaborators at Mount Sinai, Adolfo Garcia-Sastre and Florian Krammer, have been directed at developing a Universal Influenza Virus Vaccine. Since the beginning of the pandemic there has been a shift in directions as work on COVID-19 has become central to the efforts by Palese.
Palese is a Member of the National Academy of Sciences, a Member of the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, and a Fellow of the National Academy of Inventors
Instituição: Universities of East Anglia and Nottingham
Titulo da palestra: Invertebrates and Plants Virology Pushing the envelope: expanding the range of virus-like particles produced in plants
George Lomonossoff graduated from the University of Cambridge in 1976 and studied for his Ph.D. at MRC Laboratory of Molecular Biology (LMB), Cambridge. He subsequently moved to the John Innes Centre, Norwich in 1980 and has continued to work there ever since apart from two periods of sabbatical leave in the USA (Cornell University and The Scripps Research Institute). His research has focused on the molecular biology of RNA plant viruses and their use in bio- and nanotechnology. He has particularly focussed on the production of virus-like particles (VLPs) in plants. He is an honorary professor at the Universities of East Anglia and Nottingham and has co-ordinated several EU Framework consortia. In 2012 he was named “BBSRC Innovator of the year” for his work on plant-made pharmaceuticals and in 2015 delivered the Society of General Microbiology Colworth Prize Lecture. The transient expression system developed in his laboratory (CPMV-HT) has been used worldwide and is the technology currently being utilised by the Norwich-based company, Leaf Expression Systems.
PABLO R. MURCIA
Instituição: University of Glasgow
Titulo da palestra: Rhinovirus interference in SARS-CoV-2 infection
• Doctor of Philosophy (2007). University of Glasgow.
• Masters in Animal Health (2002). University of Buenos Aires, Argentina.
• Veterinarian (1998). University of Buenos Aires, Argentina.
• August 2020- present: MRC-University of Glasgow Centre for Virus Research, College of Medical, Veterinary and Life Sciences, University of Glasgow. Professor of Integrative Virology.
• August 2016- July 2020: MRC-University of Glasgow Centre for Virus Research, College of Medical, Veterinary and Life Sciences, University of Glasgow. Senior Lecturer.
• September 2012- July 2016: MRC-University of Glasgow Centre for Virus Research, College of Medical, Veterinary and Life Sciences, University of Glasgow. Lecturer.
• June 2011- September 2012: MRC-University of Glasgow Centre for Virus Research, College of Medical, Veterinary and Life Sciences, University of Glasgow. Wellcome Trust Veterinary Postdoctoral Fellow. P.I.: P. Murcia.
• September 2009- Jun2011: Department of Veterinary Medicine, University of Cambridge. Wellcome Trust Veterinary Postdoctoral Fellow. P.I.: P. Murcia.
• September 2007- September 2009: Cambridge Infectious Diseases Consortium. Department of Veterinary Medicine. University of Cambridge. Postdoctoral research associate. PI: J. Wood.
JESSE D. BLOOM
Instituição: Howard Hughes Medical Institute
Titulo da palestra: Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
• Associate Professor, Fred Hutchinson Cancer Research Center, Division of Basic Sciences and Computational Biology Program (2011 – present)
• Affiliate Associate Professor, University of Washington, Department of Genome Sciences and Department of Microbiology (2011 – present)
• Investigator, Howard Hughes Medical Institute (2018 – present)
Education and Training
• Postdoctoral fellow in Biology, Caltech, 2007-2011, advisor Dr. David Baltimore.
• Ph.D. in Chemistry, Caltech, 2002-2007, advisor Dr. Frances Arnold.
• M. Phil. in Theoretical Chemistry, Cambridge, 2001-2002, advisor Dr. David Wales.
• B.S. in Biochemistry, University of Chicago, 1997-2001, advisor Dr. Susan Lindquist
JAN FELIX DREXLER
Instituição: Charité - Universitätsmedizin Berlin, Germany
Titulo da palestra: Emerging viruses from animal reservoirs
My work focuses on the epidemiology and the evolutionary biology of emerging viruses. My major achievements include the development of affordable tests for HIV, hepatitis C virus and yellow fever virus, the uncovering of the zoonotic origins of major human viruses like mumps, hepatitis A and hepatitis B virus, and the elucidation of key aspects of the epidemiology of the Latin American Zika virus outbreak.
2017- present Associate professor (W2, fixed-term until 2022, tenure-track), Charité - Universitätsmedizin Berlin, Germany, Institute of Virology
2015-2017 Associate professor (W2, fixed-term until 2020, tenure-track), University of Bonn, Germany, Institute of Virology
2013-2014 Research associate, Erasmus University Medical Center, Rotterdam, The Netherlands, Department of Viroscience
2012 Board Certificate Microbiology, Virology and Epidemiology of Infectious Diseases (Medical association Nordrhein)
2008-2013 Staff scientist, University of Bonn Medical Centre, Germany, Institute of Virology 2003-2008 Clinical fellow, Germany, Brazil
2001-2003 Medical Thesis (Dr. med., University Hamburg) 1998-2002 Studies Spanish (Bachelor, University Hamburg)
1996-2003 Studies Medicine (University Hamburg, J. W. G.-University Frankfurt/Main)